Your Motivation, Your Goal! By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur One of the biggest challenges in meeting any goal, whether it be related to productivity, waking early, changing a habit, exercising, or just becoming happier, is finding the motivation to stick with it. If you can stick with a goal for [..]
Novartis drug Tasigna® is approved by FDA For CML By: Novartis Media Release Novartis announced that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label. Tasigna is now the first and only BCR-ABL tyrosine kinase inhibitor (TKI) to [..]
Turning Pathogens Against Each Other to Prevent Drug Resistance By: University of Michigan News Limiting a much-needed resource could pit pathogens against one another and prevent the emergence of drug resistance. New research demonstrates that harnessing competition among pathogens inside a patient could extend the life of existing drugs where resistance [..]
Research Simplified – J-Gate, an answer to a Researcher’s Quest! Patience is one of the virtues that is required in abundance if you’re a researcher or a scientist. A typical day in the life of a researcher entails him/her rummaging online to find information. You find a surplus amount of [..]
‘Medequip’: A Venture for Quality Healthcare Products Did you know that Chronic Obstructive Pulmonary Disease (COPD) is the 4th largest cause of deaths globally? COPD has been given the nickname “the silent killer” because of how it can come to be diagnosed, and for how prevalent it is, in spite [..]
Let’s Overcome the Fear of Success (Easy Confidence Trick) By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur Every time when we try something new your fear of success will arise and sabotages your mind from victory. We all have that fear of success. It’s a part of our personality and the only [..]
First Drug for Eosinophilic Granulomatosis with Polyangiitis (EGPA) of GSK Approved by FDA By: GSK News GlaxoSmithKline plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome. GSK [..]
FDA Approves Sanofi-Aventis’s Admelog to Treat Diabetes: The First Short-Acting “Follow-On” Insulin Product By: Sanofi-Aventis News The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Admelog®, the first follow-on insulin lispro to help people living with diabetes manage blood sugar levels at mealtime. “Sanofi has a deep heritage and broad [..]
This New Tool by FDA Will Help Doctors to Better Manage Antibiotic Use By: FDA News The U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. [..]
10 Things Successful People do for Motivation By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur What I’ve noticed over the time of my life is that there is a recurring pattern to successfully motivating myself. This pattern helped me get back on track, even during times that felt like rock bottom. I’ve also asked numerous executives [..]
Entrepreneur? Must Read These Books By: Vijay Soni | Founder & C.E.O. Scipreneur Reading book is the most important way to improvise yourself as a leader. Because someone who doesn’t read is going to make more dumb mistakes than someone who reads and pays attention. There are some survey books that [..]
U.S. FDA Approves Mylan and Biocon’s Ogivri™, for HER2-Positive Breast and Gastric Cancers By: PRNewswire HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India,/PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Ogivri™(trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab), co-developed with Biocon. Ogivri [..]
FDA Grants Full Approval to Genentech’s Avastin for Brain Cancer By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin®(bevacizumab) for the treatment of adults with glioblastoma that progressed following prior [..]
Copyright © 2025 | WordPress Theme by MH Themes